The present invention relates to a method for the diagnosis and/or prognosis of a neurological disease characterized by an inflammatory process as well as a method for predicting and /or monitoring the efficacy of a treatment for a neurological pathology. The methods are based on the measurement of the amount of myeloid derived microvesicles in a cerebrospinal fluid sample
Increase of myeloid microvesicles in the cerebrospinal fluid as biomarkers of microglia/microphage activation in neurological disorders
MATTEOLI, MICHELA;FURLAN, Raffaello
2011-01-01
Abstract
The present invention relates to a method for the diagnosis and/or prognosis of a neurological disease characterized by an inflammatory process as well as a method for predicting and /or monitoring the efficacy of a treatment for a neurological pathology. The methods are based on the measurement of the amount of myeloid derived microvesicles in a cerebrospinal fluid sampleFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
